made possible!
Gayathri Choda
Founder
Gayathri Choda
Company Aarca Research India Pvt. Ltd.
Certifications CDSCO, ISO
Website https://www.aarcaresearch.com/
Partnered with AMF 2023
Sector Metabolic health screening
Headquarters Bengaluru, India
Founded 2019
India’s rising tide of metabolic disorders
Globally, diabetes affects over ~460M people with over ~374M adults estimated to be on the verge of developing Type 2 diabetes. Blood tests are lab dependent and expensive, drawing blood is still painful or undesirable especially in rural areas. Early diagnosis can help prevent or delay conditions like diabetes but there are no early detection tests available until the condition reaches a clinically recognizable threshold.
IHRA- an early and non-invasive screening solution for metabolic health
IHRA (Intelligent Health Risk Assessment) is a pre-diagnostic method for early detection of Type 2 Diabetes, Hypertension, and Dyslipidemia. A 1-min video from a third party FDA-approved thermal camera is recorded and processed using artificial intelligence to predict the risk for multiple metabolic disorders- long before the condition is clinically diagnosed. The test is completely non-invasive, pain-free, instant and can be offered at as low as INR 10-50 at scale!
Aarca Research’s latest development is Hayl- a hand-held device, pocket-friendly device that allows metabolic health monitoring across 18 parameters in a completely non-invasive manner by just inserting fingers into a socket of sensors!
Impact
1
Screenings
Scale
Partnership with Government of Chhattisgarh, BrihanMumbai Municipal Corporation (BMC), Thane Municipal corporation under the NCPCDS program – screening of 30,000 patients in Mumbai to begin in August 2024
Government and NGO Partnerships
Partnership with private hospitals like KIMS hospitals and corporate screening agencies like MediBuddy, Vitality healthcare for conducting scale screening programs
Commercial Collaborations
